StockData

Broadridge Financial Solutions vs MSCI

BR and MSCI side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BR and MSCI compare

MSCI is the larger company, worth 2.2 times as much as Broadridge Financial Solutions ($45.3B against $20.4B).

On earnings, Broadridge Financial Solutions is cheaper: it trades at 18.6× trailing earnings, against 34.1× for MSCI.

MSCI grew revenue faster over the last twelve months (11.6% versus 8.5% for Broadridge Financial Solutions).

MSCI keeps more of each dollar of sales as profit, with a net margin of 40.7% compared with 15.0% at Broadridge Financial Solutions.

Both pay dividends: Broadridge Financial Solutions yields 2.2% and MSCI 1.3%.

Broadridge Financial Solutions scores higher on the StockData Score (23 against 19 for MSCI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBRMSCI
Size and price
Market cap$20.4B$45.3B
Share price$178.82$623.38
Change, 1 year−18.7%9.8%
Change, 5 years2.9%−4.6%
Beta (5Y)0.831.18
Employees16K6,268
StockData Score
Total score23 (better)19
Valuation score5 (better)2
Growth score36 (better)
Performance score6 (better)4
Health score5 (better)3
Dividend score44
Valuation
P/E18.6× (better)34.1×
P/S2.7× (better)13.6×
P/B7.2×–
EV/EBITDA16.2× (better)27.3×
P/FCF15.9× (better)28.4×
PEG0.85 (better)2.52
FCF yield6.3% (better)3.5%
Fair value$234.43$576.32
Margin of safety23.7% (better)−8.2%
Growth
Revenue growth (TTM)8.5%11.6% (better)
Revenue growth, 5Y average8.4%13.1% (better)
Net income growth (TTM)33.9% (better)15.2%
EPS growth (TTM)35.2% (better)21.1%
EPS growth, 5Y average15.6%17.1% (better)
Profitability
Gross margin31.8%83.0% (better)
Operating margin17.4%55.7% (better)
Net margin15.0%40.7% (better)
FCF margin17.1%47.9% (better)
Return on equity40.9%–
Return on invested capital18.6%47.9% (better)
Financial health
Debt / equity1.15–
Net debt / EBITDA1.98 (better)3.20
Interest coverage11.6× (better)7.2×
Current ratio1.24 (better)0.89
Altman Z-score4.086.40 (better)
Piotroski F-score88
Dividends and buybacks
Dividend yield2.2% (better)1.3%
Payout ratio39.4%42.2%
Years of dividend growth17 (better)11
Dividend growth, 5Y average11.1%19.8% (better)
Buyback yield3.0%6.0% (better)
Shareholder yield5.2%7.3% (better)
Ownership
Held by institutions94.5%92.8%
Held by insiders0.47%3.6%
Insider net buying, 12 months−$2.6M$8.5M (better)
Superinvestors holding14 (better)
Short interest, % of float2.6%2.8%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.